Product type number as specified by the Swiss Structured Products Association (SSPA): 1300
Please consult the termsheet and the accompanying issue prospectus for information on the exact product functionality, product details and risks.
| Scenario 1 | Scenario 2 | Scenario 3 | |
|---|---|---|---|
| Description | Rising underlying | Stagnating underlying | Falling underlying |
| Underlying value | 20% share A 20% share B 20% share C 20% D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
| Term | 5 years | 5 years | 5 years |
| Issue price | CHF 100 | CHF 100 | CHF 100 |
| Capital employed | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) |
| Basket at initial fixing | CHF 100 | CHF 100 | CHF 100 |
| Basket at maturity | CHF 120 | CHF 100 | CHF 80 |
| Performance basket | 20% | 0% | -20% |
| Scenario 1 | Scenario 2 | Scenario 3 | |
|---|---|---|---|
| Calculation | 100 Zertifikate * 120 | 100 Zertifikate * 100 | 100 Zertifikate * 80 |
| Redemption | CHF 12'000 | CHF 10'000 | CHF 8'000 |
| Profit / Loss | 20% | 0% | -20% |
| ZKB Barrier Reverse Convertible on worst of UBS Group AG/Helvetia Baloise Holding/Swiss Life Holding... 151092812 / CH1510928125 |
| ZKB Barrier Reverse Convertible auf UBS Group AG 151093281 / CH1510932812 |
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Geberit AG/UBS Group AG 151092088 / CH1510920882 |
| 10.0404% p.a. ZKB Callable Barrier Reverse Convertible, 19.08.2027 on worst of NESN SE/NOVN SE/ROP S... 151093164 / CH1510931640 |
| ZKB Callable Barrier Reverse Convertible on worst of Nestlé AG/Barry Callebaut AG/UBS Group AG/EMS-C... 149283732 / CH1492837328 |